Furthermore, the transition from pancreatitis to cancer is promoted by the actions of proinflammatory mediators directly on cells that harbor KRAS mutations (Guerra et al., 2011; Loncle et al., 2015; Siddiqui et al., 2018). Here, KRAS is linked to cancer.